Cleared Special

K083115 - MODIFICATION TO INTEL HEALTH GUIDE

K083115 is an FDA 510(k) clearance for MODIFICATION TO INTEL HEALTH GUIDE, manufactured by Intel Corp.. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Special 510(k) pathway after a 36-day FDA review.

K083115 · Intel Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2008
Decision
36d
Days
Class 2
Risk

K083115 is an FDA 510(k) clearance for the MODIFICATION TO INTEL HEALTH GUIDE, MODEL PHS6000. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Intel Corp. (Folsom, US). The FDA issued a Cleared decision on November 26, 2008 after a review of 36 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Intel Corp. devices

FDA 510(k) Submission Details - K083115

510(k) Number K083115 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 21, 2008
Decision Date November 26, 2008
Days to Decision 36 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
89d faster than avg
Panel avg: 125d · This submission: 36d
Pathway characteristics
Modification to existing cleared device.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 75
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K083115.
SAVI WIRELESS, MODEL PM500
K091696 · Medicomp, Inc. · Oct 2009
HOSPIRA VITAL SIGNS WIRELESS MONITORING SYSTEM
K090610 · Hospira, Inc. · Mar 2009
FORA TELEHEALTH SYSTEM
K083046 · Taidoc Technology Corporation · Jan 2009
MOTIVA MONITOR DEVICE CONNECTIVITY, MODEL# 453564036921
K071564 · Philips Medical Systems · Aug 2007
MULTIPLE PATIENT RECEIVER, MODEL ORG-9700A
K071058 · Nihon Kohden America, Inc. · Jun 2007
THE PHILIPS MP20, MP30, MP40, MP50, MP60, MP70, AND MP90 INTELLIVUE PATIENT MONITORS, WITH 802.11 WIRELESS LAN
K052961 · Philips Medical Systems · Nov 2005